This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,927.44 fixed-price delivery order covers the supply of 50 mg vials of the drug Activase, with a completion date of December 4, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award falls under that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.
Generated 3/4/25, 11:17 AM